A critical review of pharmacoecomic studies of acamprosate

Alcohol and Alcoholism

Volumn 40, Issue 5, 2005, Pages 422-430

  Poldrugo, Flavio ^a   Haeger, Doris Anita ^b   Comte, Sylvie ^c   Walburg, Jan ^c   Palmer, Andrew J ^d  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Merck Sante   (France)

^c JellinekMentrum   (Netherlands)

^d IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; DISULFIRAM; NALTREXONE; PLACEBO; DRUG DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION; TAURINE;

ALCOHOL ABSTINENCE; ALCOHOLISM; BELGIUM; CLINICAL TRIAL; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; FOLLOW UP; GERMANY; HOSPITALIZATION; HUMAN; LONG TERM CARE; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; REVIEW; SPAIN; SYSTEMATIC REVIEW; ARTICLE; COMPARATIVE STUDY; ECONOMICS; HOSPITAL READMISSION; STATISTICS;

ALCOHOL DETERRENTS; ALCOHOLISM; COHORT STUDIES; COST-BENEFIT ANALYSIS; DRUG COSTS; HUMANS; MARKOV CHAINS; PATIENT READMISSION; PROSPECTIVE STUDIES; TAURINE;

EID: 24044507326     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/agh171     Document Type: Review

References (30)

1. Annemans, L., Vanoverbeke, N., Tecco, J. et al. (2000) Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients. European Addiction Research 6, 71-78.
2. Briggs, A. and Sculpher, M. (1998) An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13, 397-409.
3. Chick J., Lehert P. and Landron, F. (2003) Does acamprosate improve reduction of drinking as well as aiding abstinence? Journal of Psychopharmacology 17, 397-402.
4. Chick, J., Rund, D. and Gilbert, M. A. (1991) Orthopaedic trauma in men: the relative risk among drinkers and the prevalence of problem drinking in male orthopaedic admissions. Annals of the Royal College of Surgeons England 73, 311-314.
5. COMBINE Study Research Group (2003) Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: Rationale and methods. Alcoholism: Clinical and Experimental Research 27, 1107-1122.
6. Finney, J. W. and Monahan, S. C. (1996) The cost-effectiveness of treatment for alcoholism: A second approximation. Journal of Studies on Alcohol 57, 229-243.
7. Gual, A. and Lehert, P. (2001) Acamprosate during and after acute alcohol withdrawal: A double-blind placebo-controlled study in Spain. Alcohol and Alcoholism 36, 413-418.
8. Hein, R. and Salomaa, J. (1999) What are the costs of substance abuse? Alcohol and drugs. Alcologia 11, 135-143.
9. Holder, H. D. (1987) Alcoholism treatment and potential health cost saving. Medical Care 25, 52-71.
10. Holder, H. D. and Blose, J. O. (1991) Typical patterns and cost of alcoholism treatment across a variety of populations and providers. Alcoholism: Clinical and Experimental Research 15, 190-195.
11. Holder, H. D. and Blose, J. O. (1992) The reduction of health care costs associated with alcoholism treatment: A 14-year longitudinal study. Journal of Studies on Alcohol 53, 293-302.
12. Holder, H. D., Cisler, R. A., Longabaugh, R. et al. (2000) Alcoholism treatment and medical care costs from Project MATCH. Addiction 95, 999-1013.
13. Holder, H. D. and Hallan, J.B. (1986) Impact of alcoholism treatment on total health care costs: A six year study. Advances in Alcohol and Substance Abuse 6, 1-15.
14. Holder, H. D., Longabaugh, R., Miller, W. R. et al. (1991) The cost effectiveness of treatment for alcoholism: A first approximation. Journal of Studies on Alcohol 52, 517-540.
15. Kiritzé-Topor, P., Huas, D., Rosenzweig, C. et al. (2004) A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care. Alcohol and Alcoholism, in press.
16. Mann, K., Lehert, P. and Morgan, M. Y. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: Results of a meta-analysis. Alcoholism: Clinical and Experimental Research 28, 51-63.
17. Mann, K. (2004) Pharmacotherapy of alcohol dependence: A review of the clinical data. CNS Drugs 18, 485-504.
18. Mason, B. J. (2001) Results of the multicenter study of acamprosate in the treatment of alcoholism. Biological Psychiatry 48 (Suppl. 8), 77S (abstract).
19. McKenna, M., Chick, J., Buxton, M. et al. (1996) The SECCAT survey: 1. The costs and consequences of alcoholism. Alcohol and Alcoholism 31, 565-576.
20. Morgan, M. Y., Landron F. and Lehert, P. (2004). Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support. Alcoholism: Clinical and Experimental Research 28, 64-77.
21. Palmer, A.J., Neeser, K., Weiss, C. et al. (2000) The long-term cost effectiveness of improving alcohol abstinence with adjuvant acamprosate. Alcohol and Alcoholism 35, 478-492.
22. Patience, D., Buxton, M., Chick, J. et al. (1997) The SECCAT survey: II. The alcohol-related problems questionnaire as a proxy for resource costs and quality of life in alcoholism treatment. Alcohol and Alcoholism 32, 79-84.
23. Pelc, I., Ansoms, C., Lehert, P. et al. (2002) The European NEAT program: An integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcoholism: Clinical and Experimental Research 26, 1529-1538.
24. Portella, E., Ridao, M., Carrillo, E. et al. (1998) El alcohol y su abuso: Impacto socioeconómico. Editorial Médica Panamericana, Madrid.
25. Reynaud, M., Gaudin-Colombel, A. F. and Le Pen, C. (2001) Two methods of estimating health costs linked to alcoholism in France (with a note on social costs). Alcohol and Alcoholism 36, 89-95.
26. Rychlik, R., Siedentop, H., Pfeil, T. et al. (2001) Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients. European Addiction Research 9, 59-64.
27. Sass, H., Soyka, M., Mann, K. et al. (1996) Relapse prevention by acamprosate: Results from a placebo controlled study in alcohol dependence. Archives of General Psychiatry 53, 673-680.
28. Schädlich, P. K. and Brecht, J. G. (1998) The cost effectiveness of acamprosate in the treatment of alcoholism: Economic evaluation of the Prevention of Relapse with Acamprosate in Management of Alcoholism (PRAMA) Study. Pharmacoeconomics 13, 719-730.
29. Whitworth, A. B., Fischer, F., Lesch, O. M. et al. (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347, 1438-1442.
30. Zook, C. J. and Moore, F. D. (1980) High cost users of medical care. The New England Journal of Medicine 302, 996-1002.